BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25064842)

  • 1. New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling.
    Lu H; Jin W; Sun J; Feng L; Lan H; Shen Q; Ma Y; Li J; Yue Y; Jin H; Wang X
    FEBS Lett; 2014 Sep; 588(18):3322-6. PubMed ID: 25064842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4.
    Lu H; Sun J; Wang F; Feng L; Ma Y; Shen Q; Jiang Z; Sun X; Wang X; Jin H
    Cell Death Dis; 2013 Aug; 4(8):e776. PubMed ID: 23949225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells.
    Hua WF; Fu YS; Liao YJ; Xia WJ; Chen YC; Zeng YX; Kung HF; Xie D
    Eur J Pharmacol; 2010 Jul; 637(1-3):16-21. PubMed ID: 20385124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes.
    Fujii S; Tokita K; Wada N; Ito K; Yamauchi C; Ito Y; Ochiai A
    Oncogene; 2011 Sep; 30(39):4118-28. PubMed ID: 21499305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
    Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
    Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway.
    Li P; Ge D; Li P; Hu F; Chu J; Chen X; Song W; Wang A; Tian G; Gu X
    J Cell Mol Med; 2020 Sep; 24(17):10151-10165. PubMed ID: 32715641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP.
    Tsai TT; Guttapalli A; Agrawal A; Albert TJ; Shapiro IM; Risbud MV
    J Bone Miner Res; 2007 Jul; 22(7):965-74. PubMed ID: 17371162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAS oncogenic signal upregulates EZH2 in pancreatic cancer.
    Fujii S; Fukamachi K; Tsuda H; Ito K; Ito Y; Ochiai A
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1074-9. PubMed ID: 22222375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
    Tandon M; Chen Z; Pratap J
    J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK1/2 inhibitors in the treatment of gynecologic malignancies.
    Miller CR; Oliver KE; Farley JH
    Gynecol Oncol; 2014 Apr; 133(1):128-37. PubMed ID: 24434059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells.
    Lv Z; Song Y; Xue D; Zhang W; Cheng Y; Xu L
    J Ethnopharmacol; 2010 Nov; 132(2):384-92. PubMed ID: 20599490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.
    Ougolkov AV; Bilim VN; Billadeau DD
    Clin Cancer Res; 2008 Nov; 14(21):6790-6. PubMed ID: 18980972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
    Andrade AA; Silva PN; Pereira AC; De Sousa LP; Ferreira PC; Gazzinelli RT; Kroon EG; Ropert C; Bonjardim CA
    Biochem J; 2004 Jul; 381(Pt 2):437-46. PubMed ID: 15025565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer.
    Han M; Dai D; Yousafzai NA; Wang F; Wang H; Zhou Q; Lu H; Xu W; Feng L; Jin H; Wang X
    Oncotarget; 2017 Nov; 8(61):103557-103567. PubMed ID: 29262584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.